Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trialsSolange Peters, Mary O’Brien, Sarah Danson et al.|Lung Cancer|2021Cited by 9
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancerFlorian Castet, Teresa Macarulla, Margherita Rimini et al.|Journal of Hepatology|2025Cited by 4